Global $20+ Billion Molecular Diagnostics Market Forecast to 2024 by Application, Technology, End User, Regions & Companies

Dublin, Dec. 13, 2018 (GLOBE NEWSWIRE) — The “Molecular Diagnostics Market, Global Forecast by Application, Technology, End User, Regions, Companies” report has been added to’s offering.

Global Molecular Diagnostics market is projected to become US$ 20.5 Billion opportunities by the year 2024, owing to a significant growth during the forecast period.

Some of the key factors that can be attributed to the growth of the molecular diagnostics market include rising prevalence of diseases, including cancers, growing awareness, and acceptance of companion & personalized diagnostics and advancement in the molecular diagnostics techniques. Furthermore; rising incidence of neurological, cardiovascular and genetic disorders also helps molecular diagnostics market thrive in the coming years.

It is believed that development in molecular diagnostics has facilitated early detection of various diseases which possibly could result in major socio-economic burden. According to WHO; the average prevalence of health care-associated infection varies between 3.5% and 12% in developed countries. While the European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. Molecular diagnostics play a significant role in the diagnosis of infectious diseases as they provide effective results in no time.

Roche, Abbott, Myriad Genetics, Qiagen, and BioMrieux are some of the top companies operating in the Molecular Diagnostics; which has been studied thoroughly in the report.

Key Topics Covered:

1. Executive Summary

2. Global Molecular Diagnostic Market

3. Market Share – Global Molecular Diagnostics
3.1 By Application
3.2 By Technology
3.3 By Countries
3.4 By Companies

4. Application – Molecular Diagnostics Market
4.1 Infectious Diseases
4.1.1 Hospital Acquired Infections (HAI)
4.1.2 HIV / HCV Testing
4.1.3 STD Testing
4.1.4 HPV Testing
4.2 Blood Screening
4.3 Oncology / Cancer
4.3.1 Breast
4.3.2 Colorectal
4.3.3 Prostate
4.3.4 Others
4.4 Genetic Testing
4.5 HLA (Tissue Typing)
4.6 Microbiology
4.7 Cardiovascular Diseases
4.8 Neurological Diseases
4.9 Pharmacogenomics
4.10 Others

5. Technology – Molecular Diagnostics Market
5.1 PCR
5.2 Transcription-Mediated Amplification (TMA)
5.3 Hybridiazation (In-situ Hybridiazation & FISH)
5.4 DNA Sequencing & NGS
5.5 Microarray
5.6 Others

6. Region – Molecular Diagnostics Market
6.1 United States
6.2 Europe
6.3 India
6.4 China
6.5 Japan
6.6 Brazil
6.7 South Korea
6.8 Mexico
6.9 Russia
6.10 Rest of World (ROW)

7. End Users – Molecular Diagnostics Market
7.1 Hospitals & Academic Laboratories
7.2 Clinics and Commercial Laboratories
7.3 Others

8. Roche Diagnostics – Company Analysis
8.1 Merger & Acquisitions
8.2 Sales Analysis

9. Abbott Laboratories – Company Analysis
9.1 Merger & Acquisitions
9.2 Sales Analysis

10. Myriad Genetics – Company Analysis
10.1 Merger & Acquisitions
10.2 Sales Analysis

11. Qiagen – Company Analysis
11.1 Merger & Acquisitions
11.2 Sales Analysis

12. BioMrieux’s Inc – Company Analysis
12.1 Merger & Acquisitions
12.2 Sales Analysis

13. Market Drivers
13.1 Various Developments in the Molecular Diagnostics Landscape
13.2 Integral to Traditional Labs
13.3 Improved Assay / Test Efficiencies
13.4 Targeting Antibiotic Resistance
13.5 Next Generation Ultrasensitive Molecular Diagnostics
13.6 Increasing Investment in Genomics & Proteomics Research
13.7 Technological Advances in Molecular Diagnostics
13.8 Increasing Acceptance of the Personalized Medicine
13.9 Growing Molecular Diagnostics for Food Safety

14. Challenges
14.1 Dearth of Trained Professionals
14.2 Regulatory Issues
14.3 Various Factors Slowing Growth of Molecular Diagnostics
14.4 Reimbursement Capabilities
14.5 Quality Checkpoints, Awareness & Acceptance

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Molecular Diagnostics